Health care

UroGen Pharma to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020

Monday, August 3, 2020 - 1:00pm

UroGen Pharma Ltd. (Nasdaq:URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases, today announced that it will report second quarter 2020 financial results on Monday, August 10, 2020, prior to the open of the market.

Key Points: 
  • UroGen Pharma Ltd. (Nasdaq:URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases, today announced that it will report second quarter 2020 financial results on Monday, August 10, 2020, prior to the open of the market.
  • The announcement will be followed by a live audio webcast and conference call at 8:30 AM Eastern Time.
  • The webcast will be made available on the Investors section of the Companys website at http://investors.urogen.com .
  • UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options.

Reata Pharmaceuticals, Inc. to Report Second Quarter 2020 Financial Results and to Provide an Update on Development Programs on August 10, 2020

Monday, August 3, 2020 - 11:45am

PLANO, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (Reata, the Company, or we), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on its development programs pre-market on August 10, 2020.

Key Points: 
  • PLANO, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (Reata, the Company, or we), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on its development programs pre-market on August 10, 2020.
  • Reatas management will host a conference call on August 10, 2020 at 8:30 a.m.
  • The conference call will be accessible by dialing (800) 708-4539 (toll-free domestic) or (847) 619-6396 (international) using the access code: 49873533.
  • Bardoxolone and omaveloxolone are investigational drugs, and their safety and efficacy have not been established by any agency.

Merck Animal Health Completes Acquisition of Worldwide Rights to VECOXAN® Brand of Parasiticides for Ruminant Portfolio

Monday, August 3, 2020 - 11:30am

Parasite control and protection is an essential and significant part of ruminant overall health management and outcomes.

Key Points: 
  • Parasite control and protection is an essential and significant part of ruminant overall health management and outcomes.
  • Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck.
  • Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them.
  • Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets.

Metabolon Announces Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany

Monday, August 3, 2020 - 8:03am

MUNICH, Germanyand MORRISVILLE, North Carolina, Aug. 3, 2020 /PRNewswire/ --Metabolon, Inc., the global leader in metabolomics, has entered into a multi-year collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company.

Key Points: 
  • MUNICH, Germanyand MORRISVILLE, North Carolina, Aug. 3, 2020 /PRNewswire/ --Metabolon, Inc., the global leader in metabolomics, has entered into a multi-year collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company.
  • Merck KGaA, Darmstadt, Germany, operates its biopharmaceuticals business in the U.S. and Canada as EMD Serono.
  • As a partner for exploratory metabolomics Metabolon will support clinical & translational research projects across therapeutic areas.
  • The execution of this long-term agreement is another important recognition of Metabolon as a world-class metabolomics solution provider."

Global Care Capital Inc. CEO Provides Corporate Update

Monday, August 3, 2020 - 7:00am

VANCOUVER, British Columbia, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Global Care Capital Inc. (CSE:HLTH, FRANKFURT:L6V1) (the Company or Global Care) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to provide a corporate update from CEO, Alex Somjen.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Global Care Capital Inc. (CSE:HLTH, FRANKFURT:L6V1) (the Company or Global Care) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to provide a corporate update from CEO, Alex Somjen.
  • We are excited about the growth prospects of our company over the next twelve months, shared Pat Gray, CEO of High Standard Health Care.
  • High Standard Health Care is a leading global PPE provider assisting front line workers during the global pandemic.
  • To date High Standard Health Care customers, include hospitals, municipalities, long-term care facilities, fire departments and police departments.

Anthem Blue Cross and Blue Shield and Yale New Haven Health System Reach a New Multi-Year Agreement

Friday, July 31, 2020 - 9:35pm

Anthem Blue Cross and Blue Shield and Yale New Haven Health System announced today that they have reached a new multi-year agreement that will maintain Yale New Haven Health Systems physicians and hospitals in Anthems network.

Key Points: 
  • Anthem Blue Cross and Blue Shield and Yale New Haven Health System announced today that they have reached a new multi-year agreement that will maintain Yale New Haven Health Systems physicians and hospitals in Anthems network.
  • We value our partnership with Yale as we work together to tackle the COVID-19 pandemic and improve lives and communities here in Connecticut, said Jill Hummel, President of Anthem Blue Cross and Blue Shield in Connecticut.
  • Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc.
  • Anthem is a registered trademark of Anthem Insurance Companies, Inc. Additional information about Anthem Blue Cross and Blue Shield in Connecticut is available at www.anthem.com .

American Family Care (AFC) Chooses Member Care Solutions to Manage Subscription Care Program in 220+ Locations Nationwide

Friday, July 31, 2020 - 4:00pm

"We are very pleased and excited to welcome AFC to the Member Care Solutions client family.

Key Points: 
  • "We are very pleased and excited to welcome AFC to the Member Care Solutions client family.
  • "Our mission from day one was to design a solution that allows patient care organizations to easily set up, execute, and manage a patient care membership program," said Member Care Solutions Founder & CEO, Darren Eilers.
  • The urgent care subscription concept is relatively new, but there are organizations with established subscription care programs out there.
  • For more information about Member Care Solutions, please visit them at https://membercaresolutions.com .

Direct Relief Distributes Thousands of 3M-Donated Advanced Respirators to Help Protect Health Workers

Friday, July 31, 2020 - 2:00pm

The devices, called powered air-purifying respirators (PAPRs), help protect healthcare workers in high-risk situations, such as when intubating severely ill Covid-19 patients.

Key Points: 
  • The devices, called powered air-purifying respirators (PAPRs), help protect healthcare workers in high-risk situations, such as when intubating severely ill Covid-19 patients.
  • 3M donated 6,000 of these devices to Direct Relief, which is distributing them to healthcare providers in need across the United States, especially to critically impacted communities in California.
  • Additionally, a PAPR's motor unit can be used by multiple health workers as long as each individual has their own hood.
  • "Direct Relief is so deeply grateful for 3M's donation of much-need PPE, which is enormously important and perfectly timed with Covid-19 cases growing," said Direct Relief President and CEO Thomas Tighe.

Maryland Patient Safety Center Names Adventist HealthCare Fort Washington Medical Center as Circle of Honor Winner for the 2020 Minogue Awards for Patient Safety Innovation

Friday, July 31, 2020 - 1:30pm

FORT WASHINGTON, Md., July 31, 2020 /PRNewswire/ -- The Maryland Patient Safety Centerrecently announced that Adventist HealthCare Fort Washington Medical Center was named a Circle of Honor winner for the 2020 Minogue Awardsfor Patient Safety Innovation.

Key Points: 
  • FORT WASHINGTON, Md., July 31, 2020 /PRNewswire/ -- The Maryland Patient Safety Centerrecently announced that Adventist HealthCare Fort Washington Medical Center was named a Circle of Honor winner for the 2020 Minogue Awardsfor Patient Safety Innovation.
  • "Patient safety is paramount, and we thank the Maryland Patient Safety Center for recognizing the hard work and vigilance of our dedicated team."
  • Adventist HealthCare Fort Washington Medical Center was one of eight hospitals throughout Maryland named a Circle of Honor winner recognizing top safety and quality solutions in healthcare.
  • The Maryland Patient Safety Center brings together healthcare organizations and providers to improve patient safety and healthcare quality for all Marylanders.

Lemonaid Health Raises Oversubscribed $33 Million Series B to Expand Telehealth Offering

Friday, July 31, 2020 - 1:00pm

SAN FRANCISCO, July 31, 2020 /PRNewswire/ -- Lemonaid Health , a convenient, affordable, on-demand platform for accessing healthcare online, has raised a $33 million Series B round of funding, bringing total financing to $55 million.

Key Points: 
  • SAN FRANCISCO, July 31, 2020 /PRNewswire/ -- Lemonaid Health , a convenient, affordable, on-demand platform for accessing healthcare online, has raised a $33 million Series B round of funding, bringing total financing to $55 million.
  • As an independent healthcare provider, Lemonaid Health offers patients direct access to the care they need, from consultation through treatment nationally across the U.S.
  • Lemonaid Health has seen a surge in demand for its services and interest from prospective partners during the COVID-19 pandemic.
  • We are excited to partner with Lemonaid Health to realize the full potential of technology in re-envisioning the future of healthcare."